MedPath

四川凯京制药有限公司

Ownership
-
Established
2008-12-17
Employees
-
Market Cap
-
Website
http://www.yy960.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

22

NMPA:22

Drug Approvals

炎热清片

Approval Number
国药准字Z20090673
Approval Date
Dec 28, 2023
NMPA

小儿青翘颗粒

Approval Number
国药准字Z20000056
Approval Date
Mar 16, 2021
NMPA

玄麦甘桔颗粒

Approval Number
国药准字Z51020034
Approval Date
Jun 17, 2020
NMPA

银柴颗粒

Approval Number
国药准字Z51020027
Approval Date
May 15, 2020
NMPA

黄连上清丸

Approval Number
国药准字Z51020028
Approval Date
May 7, 2020
NMPA

Dipyridamole Tablets

Product Name
双嘧达莫片
Approval Number
国药准字H19999016
Approval Date
Apr 24, 2020
NMPA

Metronidazole Tablets

Product Name
甲硝唑片
Approval Number
国药准字H51022536
Approval Date
Apr 15, 2020
NMPA

Vitamin B2 Tablets

Product Name
维生素B2片
Approval Number
国药准字H51020316
Approval Date
Apr 15, 2020
NMPA

Compound Paracetamol and Chlorphenamin Maleate Granules

Product Name
复方氨酚那敏颗粒
Approval Number
国药准字H51023296
Approval Date
Apr 15, 2020
NMPA

Galculus Bovis and Metronidazole Capsules

Product Name
人工牛黄甲硝唑胶囊
Approval Number
国药准字H51023298
Approval Date
Apr 15, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.